Blood test can identify patients who need more frequent monitoring or earlier surgery to prevent dissection or rupture
Vigilance for symptom emergence matters, a large 20-year analysis reveals
Phase 3 ODYSSEY-HCM trial of mavacamten leaves lingering questions about potential broader use
Our latest performance data in these areas plus HOCM and pericarditis
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Indication, timing and options for surgical intervention
Tailored valve interventions prove effective for LVOTO without significant septal hypertrophy
Reproducible technique uses native recipient tissue, avoiding risks of complex baffles
Site visits offer firsthand lessons in clinical and operational excellence in cardiovascular care
‘Concise clinical guidance’ from ACC distills key advances in imaging and pharmacotherapy
Recent Cleveland Clinic experience reveals hundreds of cases with anatomic constraints to FEVAR
Advertisement
Advertisement